Journals / Acta Medica Nicomedia / 2026 / Cilt: 9

EVALUATION OF CHILDREN DIAGNOSED WITH RAYNAUD'S PHENOMENON: A SINGLE-CENTER EXPERIENCE

RAYNAUD FENOMENİ TANILI ÇOCUKLARIN İNCELENMESİ: TEK MERKEZ DENEYİMİ

Duygu Aydın(Kocaeli Üniversitesi)0000-0001-8869-4614
Nihal Şahin(Kocaeli Üniversitesi)0000-0002-2122-6952
Pages
1–6
Publication Date
2026-03-04
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The experiences gained in our clinic, serving as a referral center, can provide valuable guidance for pediatricians managing RP in their daily practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Raynaud’s phenomenon (RP) is an episodic disorder characterized by pallor, cyanosis, and redness of the skin, often triggered by factors such as cold or emotional stress.
📊
Key Findings & Data:Methods: The study included 55 patients diagnosed with RP at Kocaeli University Department of Pediatric Rheumatology between August 2020 and January 2024.
💡
Conclusion & Impact:The experiences gained in our clinic, serving as a referral center, can provide valuable guidance for pediatricians managing RP in their daily practice.
🔬Design:Klinik Araştırma
📍Scope:2020 Verileri
⚙️Variables:Raynaud fenomeni · çocuk romatoloji · anti nükleer antikor

Abstract

Objective: Raynaud’s phenomenon (RP) is an episodic disorder characterized by pallor, cyanosis, and redness of the skin, often triggered by factors such as cold or emotional stress. It predominantly affects the fingers and less commonly the ears and nose, due to vasospasm of small arterioles. It is classified as primary or secondary based on the presence of an underlying disease. This study aimed to summarize the clinical, laboratory, and capillaroscopic features of pediatric patients diagnosed with RP. Methods: The study included 55 patients diagnosed with RP at Kocaeli University Department of Pediatric Rheumatology between August 2020 and January 2024. Results: Among the patients, 51 (92.8%) were diagnosed with primary RP, and 4 (7.2%) with secondary RP. Eighteen patients (32.7%) were male, and 37 (67.3%) were female. The median age at diagnosis was 14 years (range: 5–16.4 years). Biphasic RP was observed in 19 patients (34.5%), triphasic in 19 patients (34.5%), and monophasic in the remaining patients. Secondary RP cases had a higher frequency of antinuclear antibody positivity and enlarged capillaries on capillaroscopy. Conclusion: Most of our RP cases were primary RP. Abnormal findings on capillaroscopy were more common in secondary RP cases. The experiences gained in our clinic, serving as a referral center, can provide valuable guidance for pediatricians managing RP in their daily practice.

Özet

Amaç: Raynaud fenomeni (RF); soğuk, duygusal stres gibi çeşitli faktörlerle tetiklenebilen, ciltte solukluk, morarma ve kızarma ile karakterize; sıklıkla parmaklarda, daha az sıklıkta kulak ve burunda, küçük arteriollerin vazospazmı ile ortaya çıkan epizodik bir bozukluktur. Altta yatan bir hastalık olmamasına göre primer ve sekonder RF olarak sınıflanır. Çalışmada, RF tanısı ile takipli çocuk olgularımızın klinik, laboratuvar ve kapilleroskopik özelliklerini özetlemeyi amaçladık. Yöntem: Çalışmaya Ağustos 2020-Ocak 2024 arasında Kocaeli Üniversitesi Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Romatoloji Bilim Dalı’nda RF tanısı alan 55 hasta dahil edildi. Bulgular: Hastaların 51’ine (%92,8) primer; 4’üne (%7,2) sekonder RF tanısı konuldu. Hastaların 18’i (%32,7) erkek, 37’si (%67,3) kızdı. Hastaların medyan (minimum-maksimum) tanı yaşı 14 (5-16,4)’tü. On dokuz hastada (%34,5) bifazik, 19 hastada (%34,5) trifazik, geri kalanlarda monofazik RF saptandı. Sekonder RF’li olgularda anti nükleer antikor pozitifliği ve kapilleroskopide geniş kapil daha sık saptandı. Sonuç: Raynaud fenomeni tanılı olgularımızın daha çoğunluğu primer RF idi. Sekonder RF’si olan olgularda ise kapilleroskopide anormal bulgu oranı daha yüksekti. Referans merkezi olarak hizmet veren kliniğimizde edindiğimiz deneyimler, RF ile günlük pratiğinde ilgilenen çocuk hekimleri için rehber niteliğinde bir yol haritası sunabilir.

🔖

Cite This Article

Aydın, D., Şahin, N., Sönmez, H. E. (2026). EVALUATION OF CHILDREN DIAGNOSED WITH RAYNAUD'S PHENOMENON: A SINGLE-CENTER EXPERIENCE. Acta Medica Nicomedia, Cilt: 9, 1–6. https://doi.org/10.53446/actamednicomedia.1594888

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (26)

  1. Haque A, Hughes M. Raynaud's phenomenon. Clin Med (Lond). 2020;20(6):580-587. doi:10.7861/clinmed.2020-0520
  2. Rigante D, Fastiggi M, Ricci F, et al. Handy hints about Raynaud's phenomenon in children: A critical review. Pediatr Dermatol. 2017;34(3):235-239. doi:10.1111/pde.13118
  3. Pauling JD, Hughes M, Pope JE. Raynaud's phenomenon—an update on diagnosis, classification and management. Clin Rheumatol. 2019;38(12):3317-3330. doi:10.1007/s10067-019-04745-5
  4. Herrick AL, Wigley FM. Raynaud's phenomenon. Best Pract Res Clin Rheumatol. 2020;34(1):101474. doi:10.1016/j.berh.2020.101474
  5. Cakır N, Pamuk ÖN, Derviş E, et al. The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int. 2012;32(4):895-908. doi:10.1007/s00296-010-1707-4
  6. Humpel O, Hostoffer R. Raynaud's phenomenon. J Osteopath Med. 2024;124(1):43-44. doi:10.1515/jom-2023-0123
  7. Herrick AL. Evidence-based management of Raynaud's phenomenon. Ther Adv Musculoskelet Dis. 2017;9(12):317-329. doi:10.1177/1759720X17740074
  8. Cutolo M, Herrick AL, Distler O, et al. Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: A multicenter, prospective cohort study. Arthritis Rheumatol. 2016;68(10):2527-2539. doi:10.1002/art.39718
  9. Dundar HA, Adrovic A, Demir S, et al. Description of the characteristics of the nailfold capillary structure in healthy children: A multicentric study. Rheumatology (Oxford). 2024;63(Suppl 2):Si152-Si159. doi:10.1093/rheumatology/kead330
  10. Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun Rev. 2020;19(3):102458. doi:10.1016/j.autrev.2020.102458
  11. Smith V, Ickinger C, Hysa E, et al. Nailfold capillaroscopy. Best Pract Res Clin Rheumatol. 2023;37(3):101849. doi:10.1016/j.berh.2023.101849
  12. Karadağ ŞG, Sönmez HE, Tanatar A, et al. Profile of new referrals to a single pediatric rheumatology center in Turkey. Rheumatol Int. 2020;40(2):313-321. doi:10.1007/s00296-019-04455-9
  13. Pain CE, Constantin T, Toplak N, et al. Raynaud's syndrome in children: Systematic review and development of recommendations for assessment and monitoring. Clin Exp Rheumatol. 2016;34(Suppl 100):200-206.
  14. Esteireiro AS, Bicho A. Raynaud's phenomenon in paediatric age. BMJ Case Rep. 2020;13(5):e234881. doi:10.1136/bcr-2020-234881
  15. Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud's phenomenon in children: A retrospective review of 123 patients. Pediatrics. 2003;111(4 Pt 1):715-721. doi:10.1542/peds.111.4.715
  16. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud's phenomenon: A 5 region comparison. J Rheumatol. 1997;24(5):879-889.
  17. Temprano KK. A review of Raynaud's disease. Mo Med. 2016;113(2):123-126.
  18. Biddle K, Kaul A. Lingual Raynaud's phenomenon: A rare presentation. BMJ Case Rep. 2022;15(4):e247682. doi:10.1136/bcr-2021-247682
  19. Curtiss P, Schwager Z, Cobos G, Lo Sicco K, Franks AG Jr. A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2018;78(6):1110-1118.e3. doi:10.1016/j.jaad.2018.01.044
  20. Di Donato S, Huang S, Pauling JD, et al. Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease. Semin Arthritis Rheum. 2024;68:152521. doi:10.1016/j.semarthrit.2024.152521
  21. Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks AG Jr. Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2024;90(2):223-234. doi:10.1016/j.jaad.2023.09.027
  22. Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun. 2014;48-49:60-65. doi:10.1016/j.jaut.2014.01.020
  23. Pisetsky DS. Antinuclear antibodies in rheumatic disease: A proposal for a function-based classification. Scand J Immunol. 2012;76(3):223-228. doi:10.1111/j.1365-3083.2012.02718.x
  24. Li X, Liu X, Cui J, et al. Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population. J Clin Lab Anal. 2019;33(8):e22965. doi:10.1002/jcla.22965
  25. Batu ED, Sönmez HE, Bilginer Y. Çocuklarda Raynaud fenomeni ve birincil ve ikincil Raynaud hastalarının karşılaştırılması. Turk J Pediatr Dis. 2018;12(1):39-43. doi:10.12956/tjpd.2018.315
  26. Curtiss P, Svigos K, Schwager Z, Lo Sicco K, Franks AG Jr. Part II: The treatment of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol. 2024;90(2):237-248. doi:10.1016/j.jaad.2023.09.028